How to treat obesity combined with hyperlipidemia with medication? Scientific weight loss medication selection strategies.

Drug Selection:

1. Hypercholesterolemia For mild cases of hypercholesterolemia, niacin-based drugs are generally used; for severe cases, statins are used; and for cases primarily characterized by elevated triglycerides (TG), fibrates are used. Bile acid conjugating resins, statins, and niacin are most effective in lowering LDL cholesterol in patients with hypercholesterolemia, with statins being the most potent. Statins can also slightly increase HDL cholesterol and lower TG levels. At the same dose, simvastatin (Zocor) is twice as effective as pravastatin or lovastatin in lowering LDL cholesterol, and six times more effective than fluvastatin; while atorvastatin is more effective than simvastatin in lowering both LDL and TG. Among fibrates, fenofibrate and bezafibrate are far more effective than gemfibrozil in lowering LDL cholesterol.

For hypercholesterolemia, fenofibrate can be considered, especially for patients who do not require significant reduction in LDL cholesterol or whose initial HDL cholesterol levels are low. If a significant reduction in LDL cholesterol is necessary, the best results are achieved by combining statins and bile acid conjugating resins. Cholestyramine is more commonly used than niacin, but its use is somewhat limited due to its unpleasant taste and gastrointestinal side effects such as constipation.

2. Mixed Hyperlipidemia For the treatment of mixed hyperlipidemia, the combination of fibrates and cholestyramine is very useful, effectively lowering LDL cholesterol and TG levels. However, for some patients with refractory mixed hyperlipidemia, the combination of fibrates and statins should also be considered. If the pre-treatment TG level is <3.4~4.5mmol/L (<300~400mg/dl), a reductase inhibitor alone can be considered, especially for patients with very high LDL cholesterol. Even if these drugs cannot completely lower TG to normal, they can reduce it by about 15%, while the reduction in LDL cholesterol is very significant.

3. Hypertriglyceridemia (Hypertriglyceridemia)
Hypertriglyceridemia is mainly treated with fibrates and niacin. Fibrates, in addition to raising HDL cholesterol levels in patients with hypertriglyceridemia, can also lower their excessively high TG levels. In some patients, LDL cholesterol may not reach the target level when taking fibrates alone; in such cases, adding cholestyramine may be considered.

4. Combination Therapy
Cholestyramine combined with fibrates, and statins combined with niacin, can safely and effectively treat hyperlipidemia. While the combination of fibrates and statins is very effective, there is a risk of myopathy and rhabdomyolysis. If it is necessary to use both in combination, the patient should be carefully followed up. If a patient with hyperlipidemia has excessively high triglycerides (TG) (>11.3 mmol/L, i.e., >1000 mg/dL), fibrates alone may not be sufficient to lower TG to the target level. Fish oil preparations, such as Maxepa at 3-6 g daily, must be added.

(IV) Adverse Reactions of Lipid-Lowering Drugs
In clinical application, most lipid-lowering drugs rarely cause significant side effects. Except for niacin and cholestyramine, patients generally tolerate them well. The main side effects of statins are transient headache, fatigue, gastrointestinal reactions, abnormal liver function, and myopathy. Therefore, regular monitoring of serum creatine phosphokinase (SCPK) and liver enzyme levels is necessary (every 3-6 months). The incidence of drug-induced abnormalities in liver function and SCPK is low and generally mild, requiring no discontinuation of the drug. Some fibrates can increase the gallstone formation index; therefore, these drugs are generally contraindicated in patients with gallstones or gallbladder disease.